Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization

Genes Chromosomes and Cancer

Volumn 23, Issue 2, 1998, Pages 141-152

  Vandesompele, Jo ^a   Van Roy, Nadine ^a   Van Gele, Mireille ^a   Laureys, Geneviève ^a   Ambros, Peter ^b   Heimann, Pierre ^c   Devalck, Christine ^c   Schuuring, Ed ^d   Brock, Penelope ^e   Otten, Jacques ^f   Gyselinck, Jan ^g   De Paepe, Anne ^a   Speleman, Frank ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^c Children's Hospital   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f University Hospital Center   (Belgium)

^g Children's Hospital   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA, NEOPLASM; GENE AMPLIFICATION; GENETIC HETEROGENEITY; HUMANS; INFANT; INFANT, NEWBORN; LOSS OF HETEROZYGOSITY; MALE; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION;

EID: 0031665929     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199810)23:2<141::AID-GCC7>3.0.CO;2-2     Document Type: Article

References (39)

1. Altura RA, Maris JM, Li H, Boyett JM, Brodeur GM, Look AT (1947) Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization. Genes Chromosomes Cancer 19:176-184.
2. Ambrosini G, Adida C, Altieri DC (1997) A novel antiapoptosis gene, survivine, expressed in cancer and lymphoma. Nature Med 3:917-921.
3. Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F, Stoerkel S (1997) Comparative genomic hybridization (CGH) analysis of neuroblastomas: An important methodological approach in paediatric tumour pathology. J Pathol 181:394-400.
4. Brodeur GM, Castleberry RP (1993) Neuroblastoma. In Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology, 2nd ed. Philadelphia: Lippincott, pp 739-761.
5. Caron H, van Sluis P, Van Roy N, de Kraker J, Speleman F, Voute PA, Westerveld A, Slater R, Versteeg R (1994) Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341-347.
6. Caron H, van Sluis P, Buschman R, Pereira-do-Tanque R, Maes P, Beks L, de Kraker J, Voute PA, Vergnaud G, Westerveld A, Slater R, Versteeg R (1996) Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus. Hum Genet 97:834-837.
7. du Manoir S, Speicher MR, Joos S, Schrock E, Popp S, Dohner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T (1993) Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610.
8. du Manoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T (1995) Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
9. Kong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM (1992) Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780-1785.
10. Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, Podolsky R, Rinaldt V, Vinikoor N, Weisband J (1984) Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 44:5444-5449.
11. Hallstensson K, Tholin S, Aburatani H, Hippo Y, Martinsson T (1997) RDA and LOH studies detect 3p deletions in neuroblastoma. Eur J Cancer 33:1966-1970.
12. Hayashi Y, Inaba T, Hanada R, Yamamoto K (1988) Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening. J Pediatr 112:567-571.
13. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
14. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
15. Lastowska M, Cotterill S, Pearson AD, Roberts P, McGuckin A, Lewis I, Bown N (1997a) Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group. Eur J Cancer 33:1627-1633.
16. Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N (1997b) Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Genes Chromosomes Cancer 18:162-169.
17. Lastowska M, Roberts P, Pearson ADJ, Lewis I, Wolstenholme J, Bown N (1997c) Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosomes Cancer 19:143-149.
18. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Strain D, Slamon DJ, Steeg PS (1993) Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8:855-865.
19. Look AT, Haves FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:581-591.
20. Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Yanofsky RA, Feldman GL, Brodeur GM (1996) Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Res 56:3421-3425.
21. Meddeb M, Danglot G, Chudoba I, Venuat AM, Benard J, Avet-Loiseau H, Vasseur B, Le-Paslier D, Terrier-Lacombe MJ, Hartmann O, Bernheim A (1996) Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qte are present in 90% of high-grade neuroblastomas. Genes Chromosomes Cancer 17:156-165.
22. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG (1997) Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150:81-89.
23. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, Biedler JL (1995) Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 6:449-456.
24. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
25. Savelyeva L, Corvi R, Schwab M (1994) Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334-340.
26. Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene 159:83-96.
27. Srivatsan ES, Murali V, Seeger RC (1991) Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma. Prog Clin Biol Res 366:91-98.
28. Srivatsan ES, Ying KL, Seeger RC (1993) Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosomes Cancer 7:32-37.
29. Strehl S, Ambros PF (1993) Fluorescence in situ hybridization combined with immunohistochemistry for highly sensitive detection of chromosome 1 aberrations in neuroblastoma. Cytogenet Cell Genet 63:24-28.
30. Suzuki T, Yokota J, Mugishima H, Okabe I, Ookuni M, Sugimura T, Terada M (1989) Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 49:1095-1098.
31. Suzuki T, Mugishima H, Fujisawa T, Okuni M, Okabe I, Yokota J, Terada M (1991) Loss of heterozygosity on chromosome 14 in neuroblastoma. Prog Clin Biol Res 366:135-145.
32. Takayama H, Suzuki T, Mugishima H, Fujisawa T, Ookuni M, Schwab M, Gehring M, Nakamura Y, Sugimura T, Terada M. (1992) Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene 7:1185-1189.
33. Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J (1995) Allelotype of neuroblastoma. Oncogene 11:1829-1834.
34. Van Gele M, Van Roy N, Jauch A, Laureys G, Schelfhout V, De Potter CR, Brock P, Uyttebroeck A, Sciot R, Schuuting E, Versteeg R, Speleman F (1997) Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridization analysis. Eur J Cancer 33:1979-1982.
35. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F (1994) 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 10:103-114.
36. Van Roy N, Cheng NC, Laureys G, Opdenakker G, Versteeg R, Speleman F (1995a) Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma, Eur J Cancer 31A:530-535.
37. Van Roy N, Forus A, Myklebost O, Cheng NC, Versteeg R, Speleman F (1995b) Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP. Cancer Genet Cytogenet 82:151-154.
38. Van Roy N, Jauch A, Van Gele M, Laureys G, Versteeg R, De Paepe A, Cremer T, Speleman F (1997) Comparative genomic hybridization analysis of human neuroblastomas: Detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines. Cancer Genet Cytogenet 82:151-154.
39. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM (1997) Targeted expression of MYCN causes neuroblastoma in transgenic mice. Embo J 16:2985-2995.